JPRN-UMIN000016148已完成2 期
Evaluation of safety and efficacy to abatacept treatment of patients with HBV-related acute liver failure.-Pilot Study- - A pilot study of abatacept treatment in actu HBV patients with liver failure.
Hiroshima liver study group0 个研究点目标入组 5 人开始时间: 2015年1月7日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Autoimmune hepatitis 2)History of hypersensitivity to abatacept 3)Hepatic coma 4)HBV carrier 5)Serious infectious disease 6)Judged by investigator not to be appropriate for inclusion in this study
研究者
相似试验
已完成
不适用
Analysis of Effectiveness and Safety of Abatacept in Japanese patients with Rheumatoid Arthritis.Rheumatoid arthritisJPRN-UMIN000005144Tokyo Medical and Dental university300
已完成
2 期
Safety and Efficacy of abatacept (s.c.) in patients with CTLA4 insufficiency or LRBA deficiencyCTLA4 insufficiency or LRBA deficiencyD84.9Immunodeficiency, unspecifiedDRKS00017736niversitätsklinikum Freiburg vertreten durch den Leitenden Ärztlichen Direktor und die Kaufmännische Direktorin20
进行中（未招募）
1 期
Examination of the drug abatacept (administered as syringe under the skin) in patients suffering from CTLA4 insufficiency or LRBA deficienca. Focus of inverstigation: side effects and effects on the clinical symptoms examined.Patients with a molecular confirmed diagnosis of CTLA4 (cytotoxic T-lymphocyte-associated Protein 4) (haplo)-insufficiency or LRBA (Lipopolysaccharide-Responsive and Beige-like An¬chor) deficiencyMedDRA version: 20.1Level: PTClassification code 10021449Term: Immunodeficiency common variableSystem Organ Class: 10021428 - Immune system disordersEUCTR2019-000972-40-DEniversitätsklinikum Freiburg20
进行中（未招募）
1 期
Aflibercept Efficacy in Patients Suffering Age-Related Damage of the Yellow Spot of the Light-sensitive Tissue Layer in the EyeEUCTR2014-002168-34-CZDoc. MUDr. Petr Kolár, PhD, Ocní klinika FN Brno45
已完成
2 期
Safety and efficacy of Abatacept in patients with treatment-resistant sarcoidosisD86.0Sarcoidosis of lungDRKS00011660niversitätsklinikum Freiburg30